In This Section

Board of Directors

Nina Bhardwaj, MD, PhD

Nina Bhardwaj, MD, PhD

(2021-2024)

Ward Coleman Chair in Cancer Research
Director of Immunotherapy
Medical Director, Vaccine and Cell Therapy Laboratory
Codirector, Cancer Immunology Program
The Tisch Cancer Institute
Icahn School of Medicine at Mt. Sinai
New York, New York

John D. Carpten, PhD, FAACR

John D. Carpten, PhD, FAACR

(2021-2025)

Professor and Chair, Department of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Professor, Department of Urology
Co-director, Institute for Translational Genomics
Director, USC Molecular Genomics Core
Co-leader, NCCC Translational and Clinical Sciences Program
PI-CaRE2 Health Equity Center at USC
Keck School of Medicine
University of Southern California

John M. Carethers, MD

John M. Carethers, MD

(2023-2026)

Vice Chancellor for Health Sciences
University of California San Diego

Christina Curtis, PhD, MSc

Christina Curtis, PhD, MSc

(2022-2025)

Professor of Medicine, Genetics, and Biomedical Data Science
Director, Breast Cancer Translational Research
Co-director, Molecular Tumor Board
Stanford University
Investigator, Chan Zuckerberg Biohub
Stanford, California

Luis A. Diaz Jr., MD, FAACR

Luis A. Diaz Jr., MD, FAACR

(2021-2024)

Grayer Family Chair
Head, Division of Solid Tumor Oncology
Memorial Sloan Kettering Cancer Center
New York, New York

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

(2021-2024)

Executive Vice-President
Oncology R&D
AstraZeneca
Cambridge, England

Christine M. Lovly, MD, PhD

Christine M. Lovly, MD, PhD

(2023-2026)

Associate Professor of Medicine, Division of Hematology-Oncology
Ingram Associate Professor of Cancer Research
Co-leader, Translational Research and Interventional Oncology Program
Vanderbilt University Medical Center
Vanderbilt Ingram Cancer Center

Thomas J. Lynch Jr., MD

Thomas J. Lynch Jr., MD

(2021-2024)

President and Director
Raisbeck Endowed Chair
Fred Hutchinson Cancer Research Center
Seattle, Washington

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

(2021-2024)

Chief, Section of Breast Surgery
New York-Presbyterian/Weill Cornell Medical Center
Leader, Multidisciplinary Breast Oncology Programs
New York-Presbyterian David H. Koch Center
Weill Cornell Medicine

William Pao, MD, PhD

William Pao, MD, PhD

(2022-2025)

Chief Development Officer and Executive Vice President
Pfizer

Elizabeth A. Platz, ScD, MPH

Elizabeth A. Platz, ScD, MPH

(2023-2026)

Professor and Martin D. Abeloff, MD, Scholar in Cancer Prevention
Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Alice T. Shaw, MD, PhD

Alice T. Shaw, MD, PhD

(2023-2026)

Global Head, Translational Clinical Oncology
Novartis Institutes for Biomedical Research

Kimberly Stegmaier, MD

Kimberly Stegmaier, MD

(2022-2025)

Professor of Pediatrics at Harvard Medical School
Ted Williams Investigator, Dana-Farber Cancer Institute
Boston, Massachusetts

Robert H. Vonderheide, MD, DPhil

Robert H. Vonderheide, MD, DPhil

(2022-2025)

Director, Abramson Cancer Center
Vice Dean and Vice President of Cancer Programs
Perelman School of Medicine and the University of Pennsylvania Health System
Philadelphia, Pennsylvania

Jedd Wolchok, MD, PhD, FASCO, FAACR

Jedd Wolchok, MD, PhD, FASCO, FAACR

(2023-2026)

Director, Sandra and Edward Meyer Cancer Center
Professor of Medicine
Weill Cornell Medicine

View the list of past board members.